US 6,982,253 B2 | ||
Liquid formulation of decitabine and use of the same | ||
Rajashree Joshi-Hangal, Union City, Calif. (US); Xichen Zhang, Thousand Oaks, Calif. (US); Stephanie Gong, Pleasanton, Calif. (US); Sanjeev Redkar, Union City, Calif. (US); and Ashok Y. Gore, San Ramon, Calif. (US) | ||
Assigned to SuperGen, Inc., Dublin, Calif. (US) | ||
Filed on Jun. 05, 2002, as Appl. No. 10/164,276. | ||
Prior Publication US 2003/0229047 A1, Dec. 11, 2003 | ||
Int. Cl. A01N 43/04 (2006.01); A61K 31/70 (2006.01) |
U.S. Cl. 514—49 | 79 Claims |
1. A pharmaceutical formulation for administering decitabine to a host in need thereof, comprising:
decitabine solvated in a solvent that comprises glycerin, propylene glycol, polyethylene glycol, or combinations thereof,
and comprises less than 40% water.
|